| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
28,240 |
20,277 |
$3.28M |
| H2020 |
Therapeutic behavioral services, per diem |
2,682 |
1,379 |
$216K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,689 |
9,406 |
$256.64 |
| 90834 |
Psychotherapy, 45 minutes with patient |
619 |
401 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
331 |
304 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,835 |
7,843 |
$0.00 |
| 87276 |
|
339 |
304 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,678 |
1,218 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,522 |
2,220 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,447 |
1,154 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
101 |
91 |
$0.00 |
| 86769 |
|
60 |
45 |
$0.00 |
| 92551 |
|
82 |
64 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
186 |
141 |
$0.00 |
| 82962 |
|
1,685 |
1,262 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
317 |
220 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
187 |
133 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
262 |
178 |
$0.00 |
| 96127 |
|
67 |
51 |
$0.00 |
| 90677 |
|
14 |
12 |
$0.00 |
| 90656 |
|
19 |
14 |
$0.00 |
| 87807 |
|
44 |
27 |
$0.00 |
| 81003 |
|
2,835 |
1,662 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,090 |
820 |
$0.00 |
| 90633 |
|
15 |
14 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
407 |
327 |
$0.00 |
| 99173 |
|
237 |
175 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
701 |
576 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
410 |
302 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
228 |
188 |
$0.00 |
| 81025 |
|
413 |
293 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,430 |
1,140 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
241 |
198 |
$0.00 |
| 1159F |
|
107 |
86 |
$0.00 |
| 1160F |
|
123 |
98 |
$0.00 |
| 87275 |
|
339 |
304 |
$0.00 |
| 82948 |
|
289 |
225 |
$0.00 |
| 90461 |
|
325 |
261 |
$0.00 |
| 82947 |
|
382 |
319 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
209 |
112 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
21 |
12 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
25 |
18 |
$0.00 |
| 11721 |
|
22 |
12 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
45 |
26 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
32 |
27 |
$0.00 |